Your browser doesn't support javascript.
loading
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Talukder, Rafee; Makrakis, Dimitrios; Diamantopoulos, Leonidas N; Carril-Ajuria, Lucia; Castellano, Daniel; De Kouchkovsky, Ivan; Koshkin, Vadim S; Park, Joseph J; Alva, Ajjai; Bilen, Mehmet A; Stewart, Tyler F; McKay, Rana R; Santos, Victor S; Agarwal, Neeraj; Jain, Jayanshu; Zakharia, Yousef; Morales-Barrera, Rafael; Devitt, Michael E; Grant, Michael; Lythgoe, Mark P; Pinato, David J; Nelson, Ariel; Hoimes, Christopher J; Shreck, Evan; Gartrell, Benjamin A; Sankin, Alex; Tripathi, Abhishek; Zakopoulou, Roubini; Bamias, Aristotelis; Murgic, Jure; Fröbe, Ana; Rodriguez-Vida, Alejo; Drakaki, Alexandra; Liu, Sandy; Kumar, Vivek; Lorenzo, Giuseppe Di; Joshi, Monika; Velho, Pedro Isaacsson; Buznego, Lucia Alonso; Duran, Ignacio; Moses, Marcus; Barata, Pedro; Sonpavde, Guru; Yu, Evan Y; Wright, Jonathan L; Grivas, Petros; Khaki, Ali Raza.
Afiliação
  • Talukder R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Makrakis D; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Diamantopoulos LN; Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Carril-Ajuria L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • De Kouchkovsky I; Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Koshkin VS; Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Park JJ; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI.
  • Alva A; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI.
  • Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Stewart TF; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA.
  • McKay RR; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA.
  • Santos VS; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT.
  • Agarwal N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT.
  • Jain J; Department of Medicine, University of Iowa, Iowa City, IA.
  • Zakharia Y; Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA.
  • Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Devitt ME; Division of Hematology/Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA.
  • Grant M; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Lythgoe MP; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Nelson A; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Hoimes CJ; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH; Division of Medical Oncology, Duke University, Durham, NC.
  • Shreck E; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY.
  • Gartrell BA; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY.
  • Sankin A; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY.
  • Tripathi A; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Zakopoulou R; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Bamias A; 2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, School of Dental Medicine, Zagreb, Croatia.
  • Fröbe A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, School of Dental Medicine, Zagreb, Croatia.
  • Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain.
  • Drakaki A; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
  • Liu S; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
  • Kumar V; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Lorenzo GD; Oncology University of Molise and ASL, Salerno, Italy.
  • Joshi M; Division of Hematology/Oncology, Department of Medicine, Penn State Cancer Institute, Hershey, PA.
  • Velho PI; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Buznego LA; Hospital Universitario Marques de Valdecilla. IDIVAL. Santander, Spain.
  • Duran I; Hospital Universitario Marques de Valdecilla. IDIVAL. Santander, Spain.
  • Moses M; Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA.
  • Barata P; Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA.
  • Sonpavde G; Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Yu EY; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Wright JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Urology, University of Washington, Seattle, WA.
  • Grivas P; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address: pgrivas@uw.edu.
  • Khaki AR; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA. Electronic address: alikhaki@stanford.edu.
Clin Genitourin Cancer ; 20(2): 165-175, 2022 04.
Article em En | MEDLINE | ID: mdl-35078711
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article